Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Polycythemia Vera × Erlotinib Hydrochloride × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 275 Lung Neoplasms 98 Pancreatic Neoplasms 64 Neoplasms 46 Brain Neoplasms 28 Neoplasm Metastasis 27 Glioblastoma 23 Breast Neoplasms 23 Squamous Cell Carcinoma of Head and Neck 22 Gliosarcoma 21 Head and Neck Neoplasms 20 Adenocarcinoma of Lung 20 Colorectal Neoplasms 17 Non-Squamous Non-Small Cell Lung Cancer 16 Carcinoma, Hepatocellular 15 Carcinoma, Renal Cell 13 Adenocarcinoma, Bronchiolo-Alveolar 13 Rectal Neoplasms 12 Colonic Neoplasms 12 Glioma 11 Esophageal Neoplasms 11 Astrocytoma 11 Salivary Gland Neoplasms 8 Oligodendroglioma 8 Gallbladder Neoplasms 8 Central Nervous System Neoplasms 8 Carcinoma, Squamous Cell 8 Ovarian Neoplasms 7 Carcinoma, Ovarian Epithelial 7 Bile Duct Neoplasms 7

Interventions

fludarabine phosphate 27 Peripheral Blood Stem Cell Transplantation 22 Cyclophosphamide 22 ruxolitinib 21 Busulfan 17 Whole-Body Irradiation 14 Mycophenolic Acid 13 Tacrolimus 12 Cyclosporine 11 Methotrexate 10 Antilymphocyte Serum 10 fludarabine 8 Aspirin 8 Melphalan 7 Hydroxyurea 7 Filgrastim 7 Etoposide 7 Decitabine 7 Cytarabine 6 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 6 peginterferon alfa-2a 5 givinostat hydrochloride 5 givinostat 5 Radiotherapy 5 Biopsy 5 Stem Cell Transplantation 4 Prednisone 4 Phlebotomy 4 Methylprednisolone 4 Imatinib Mesylate 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01038856 2020-08-24

OSI-TAR-766

University of Oklahoma

Phase 2 Terminated

5 enrolled 6 charts

Polycythemia Vera

Data powered by HemOnc (CC BY 4.0) Colophon ⚡